Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

2.

Epidemiology of HPV infection and current status of cervical cancer prevention in Greece: final results of the LYSISTRATA cross-sectional study.

Agorastos T, Chatzistamatiou K, Zafrakas M, Siamanta V, Katsamagkas T, Constantinidis TC, Lampropoulos AF; LYSISTRATA study group.

Eur J Cancer Prev. 2014 Sep;23(5):425-31. doi: 10.1097/CEJ.0000000000000060.

PMID:
24977385
3.

Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine.

Sotiriadis A, Dagklis T, Siamanta V, Chatzigeorgiou K, Agorastos T; LYSISTRATA Study Group.

Arch Gynecol Obstet. 2012 Jun;285(6):1719-24. doi: 10.1007/s00404-011-2208-z. Epub 2012 Jan 14.

PMID:
22246478
4.

Prevalence and distribution of high-risk human papillomavirus in Greece.

Agorastos T, Lambropoulos AF, Sotiriadis A, Mikos T, Togaridou E, Emmanouilides CJ.

Eur J Cancer Prev. 2009 Nov;18(6):504-9. doi: 10.1097/CEJ.0b013e32832abd5e.

PMID:
19741545
5.

Aggressive angiomyxoma of the vulva extending into the pelvis: report of two cases.

Dragoumis K, Drevelengas A, Chatzigeorgiou K, Assimakopoulos E, Venizelos I, Togaridou E, Mikos T, Boulogianni G, Bontis J.

J Obstet Gynaecol Res. 2005 Aug;31(4):310-3.

PMID:
16018777
6.

Abdominal myomectomy and febrile morbidity.

Vavilis D, Togaridou E, Agorastos T.

Int J Gynaecol Obstet. 2005 Jan;88(1):61-2. No abstract available.

PMID:
15617711

Supplemental Content

Loading ...
Support Center